Cannara Biotech Inc. (LOVE.TO) saw its stock price drop by 2.67% in the last trading session, closing at CA$1.82. This decline raises concerns about the company's future in a tough market.
Investor takeaway: Investors should be cautious as Cannara's stock shows signs of weakness, especially with no recent positive news to boost confidence.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cannara Biotech Inc.
LOVE.TO
LOVE.TO
Cannara Biotech Inc.
WealthAwesomeMarket cap
$187.69M
P/E
17.3x
52W high
$2.05
52W low
$1.55
1W change
+1.60%
Beta
0.35
Analyst Price Targets
Based on analyst covering LOVE
Wall Street analysts forecast LOVE stock price to rise 76.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+76.7% Upside
Current Price
C$1.91
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
40.3%
Annualized
90-Day Vol
36.1%
Annualized
Trend (90d)
+34.4%
Annualized drift
90d Mean
C$2.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.99 | C$1.73 – C$2.29 |
| 60 trading days | C$2.07 | C$1.70 – C$2.52 |
| 90 trading days | C$2.16 | C$1.70 – C$2.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Cannara Biotech Inc. down 2.67% in one day
With a market cap of CA$181.76 million, Cannara is relatively small in the market, making it more vulnerable to fluctuations.
Bull case
Despite the recent decline, Cannara has secured exclusive rights to innovative technology that could improve its product offerings and strengthen its market position in the future.
Bear case
The recent performance of Cannara's stock reflects broader concerns about market volatility and the company's ability to stay profitable amid growing competition.
Recent Performance Overview
Advertisement
Cannara Biotech Inc. closed down 2.67% yesterday, highlighting investor uncertainty. Given its market cap of CA$181.76 million, the stock's volatility is a concern for potential investors. For more insights on Cannara's recent performance, check out our detailed analysis on LOVE.TO.
Market Context and Investor Sentiment
The drop in Cannara's stock price comes as small-cap companies face increased scrutiny in the broader market. Investors should consider the implications of Cannara's recent announcements, including its acquisition of Medican Organic Inc., as discussed in our latest updates on LOVE.TO.
Future Outlook
Looking ahead, Cannara's recent acquisition and technology rights could set the stage for future growth, but the current market sentiment suggests caution. For ongoing updates and expert analysis, follow our coverage on LOVE.TO.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
